{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:39:29Z","timestamp":1758818369343,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:00:00Z","timestamp":1619049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11695-021-05438-2","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T17:02:41Z","timestamp":1619110961000},"page":"3874-3879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Phentermine-Induced Acute Kidney Injury Secondary to Uncontrolled Hypertension in a Patient with Weight Regain Post-bariatric Surgery"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9946-0565","authenticated-orcid":false,"given":"Marvin Wei Jie","family":"Chua","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boon Cheok","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,22]]},"reference":[{"issue":"3","key":"5438_CR1","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMra1514009","volume":"376","author":"SB Heymsfield","year":"2017","unstructured":"Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254\u201366. https:\/\/doi.org\/10.1056\/NEJMra1514009.","journal-title":"N Engl J Med"},{"issue":"6","key":"5438_CR2","doi-asserted-by":"publisher","first-page":"802","DOI":"10.4093\/dmj.2020.0258","volume":"44","author":"JW Son","year":"2020","unstructured":"Son JW, Kim S. Comprehensive review of current and upcoming anti-obesity drugs. Diabetes Metab J. 2020;44(6):802\u201318. https:\/\/doi.org\/10.4093\/dmj.2020.0258.","journal-title":"Diabetes Metab J"},{"key":"5438_CR3","doi-asserted-by":"publisher","unstructured":"Tak YJ, Lee SY. Long-term efficacy and safety of anti-obesity treatment: where do we stand? Curr Obes Rep. 2021:14\u201330. https:\/\/doi.org\/10.1007\/s13679-020-00422-w.","DOI":"10.1007\/s13679-020-00422-w"},{"key":"5438_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/978-3-642-24716-3_20","volume":"209","author":"J Antel","year":"2012","unstructured":"Antel J, Hebebrand J. Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide. Handb Exp Pharmacol. 2012;209:433\u201366. https:\/\/doi.org\/10.1007\/978-3-642-24716-3_20.","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"5438_CR5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/oby.2011.330","volume":"20","author":"DB Allison","year":"2012","unstructured":"Allison DB, Gadde KM, Garvey WT, et al. Controlled-release phentermine\/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obes Silver Spring Md. 2012;20(2):330\u201342. https:\/\/doi.org\/10.1038\/oby.2011.330.","journal-title":"Obes Silver Spring Md"},{"issue":"9774","key":"5438_CR6","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","volume":"377","author":"KM Gadde","year":"2011","unstructured":"Gadde KM, Allison DB, Ryan DH, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet Lond Engl. 2011;377(9774):1341\u201352. https:\/\/doi.org\/10.1016\/S0140-6736(11)60205-5.","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"5438_CR7","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3945\/ajcn.111.024927","volume":"95","author":"WT Garvey","year":"2012","unstructured":"Garvey WT, Ryan DH, Look M, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine\/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95(2):297\u2013308. https:\/\/doi.org\/10.3945\/ajcn.111.024927.","journal-title":"Am J Clin Nutr"},{"issue":"22","key":"5438_CR8","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1001\/jama.2016.7602","volume":"315","author":"R Khera","year":"2016","unstructured":"Khera R, Murad MH, Chandar AK, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424\u201334. https:\/\/doi.org\/10.1001\/jama.2016.7602.","journal-title":"JAMA."},{"issue":"2","key":"5438_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11906-019-0915-1","volume":"21","author":"JB Cohen","year":"2019","unstructured":"Cohen JB, Gadde KM. Weight loss medications in the treatment of obesity and hypertension. Curr Hypertens Rep. 2019;21(2):16. https:\/\/doi.org\/10.1007\/s11906-019-0915-1.","journal-title":"Curr Hypertens Rep"},{"issue":"6","key":"5438_CR10","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1002\/oby.22786","volume":"28","author":"NW Istfan","year":"2020","unstructured":"Istfan NW, Anderson WA, Hess DT, et al. The mitigating effect of phentermine and topiramate on weight regain after roux-en-y gastric bypass surgery. Obes Silver Spring Md. 2020;28(6):1023\u201330. https:\/\/doi.org\/10.1002\/oby.22786.","journal-title":"Obes Silver Spring Md"},{"key":"5438_CR11","doi-asserted-by":"publisher","unstructured":"Edgerton C, Mehta M, Mou D, Dey T, Khaodhiar L, Tavakkoli A. Patterns of weight loss medication utilization and outcomes following bariatric surgery. J Gastrointest Surg Off J Soc Surg Aliment Tract, 2021. doi:https:\/\/doi.org\/10.1007\/s11605-020-04880-4","DOI":"10.1007\/s11605-020-04880-4"},{"issue":"Suppl 4","key":"5438_CR12","doi-asserted-by":"publisher","first-page":"iv82","DOI":"10.1093\/ndt\/gft302","volume":"28","author":"D Bolignano","year":"2013","unstructured":"Bolignano D, Zoccali C. Effects of weight loss on renal function in obese CKD patients: a systematic review. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2013;28(Suppl 4):iv82\u201398. https:\/\/doi.org\/10.1093\/ndt\/gft302.","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"2","key":"5438_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345. https:\/\/doi.org\/10.1038\/clpt.1981.154.","journal-title":"Clin Pharmacol Ther"},{"key":"5438_CR14","doi-asserted-by":"publisher","unstructured":"Shao EX, Wilson GJ, Ranganathan D. Phentermine induced acute interstitial nephritis. BMJ Case Rep. 2017;2017 https:\/\/doi.org\/10.1136\/bcr-2017-219452.","DOI":"10.1136\/bcr-2017-219452"},{"issue":"22","key":"5438_CR15","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.2146\/ajhp090395","volume":"67","author":"KE Steidl","year":"2010","unstructured":"Steidl KE, Darko W, Probst LA, et al. Rhabdomyolysis associated with phentermine. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 2010;67(22):1929\u201332. https:\/\/doi.org\/10.2146\/ajhp090395.","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"issue":"11 Suppl 1","key":"5438_CR16","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1210\/jc.2008-1294","volume":"93","author":"GA Bray","year":"2008","unstructured":"Bray GA. Lifestyle and pharmacological approaches to weight loss: efficacy and safety. J Clin Endocrinol Metab. 2008;93(11 Suppl 1):S81\u20138. https:\/\/doi.org\/10.1210\/jc.2008-1294.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5438_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.gtc.2010.01.001","volume":"39","author":"LM Kaplan","year":"2010","unstructured":"Kaplan LM. Pharmacologic therapies for obesity. Gastroenterol Clin N Am. 2010;39(1):69\u201379. https:\/\/doi.org\/10.1016\/j.gtc.2010.01.001.","journal-title":"Gastroenterol Clin N Am"},{"issue":"12","key":"5438_CR18","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1038\/oby.2011.94","volume":"19","author":"EJ Hendricks","year":"2011","unstructured":"Hendricks EJ, Greenway FL, Westman EC, et al. Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity. Obes Silver Spring Md. 2011;19(12):2351\u201360. https:\/\/doi.org\/10.1038\/oby.2011.94.","journal-title":"Obes Silver Spring Md"},{"issue":"5","key":"5438_CR19","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3349\/ymj.2006.47.5.614","volume":"47","author":"KK Kim","year":"2006","unstructured":"Kim KK, Cho H-J, Kang H-C, et al. Effects on weight reduction and safety of short-term phentermine administration in Korean obese people. Yonsei Med J. 2006;47(5):614\u201325. https:\/\/doi.org\/10.3349\/ymj.2006.47.5.614.","journal-title":"Yonsei Med J"},{"issue":"1","key":"5438_CR20","doi-asserted-by":"publisher","first-page":"30510","DOI":"10.3402\/jchimp.v6.30510","volume":"6","author":"MG Meseeha","year":"2016","unstructured":"Meseeha MG, Attia MN, Kolade VO. Topiramate as a rare cause of reversible Fanconi syndrome and acute kidney injury: a case report and literature review. J Community Hosp Intern Med Perspect. 2016;6(1):30510. https:\/\/doi.org\/10.3402\/jchimp.v6.30510.","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"2","key":"5438_CR21","first-page":"105","volume":"27","author":"R Ferriols Lisart","year":"2003","unstructured":"Ferriols Lisart R, Heras Javierre A, Sanz Mu\u00f1oz M, et al. Acute renal failure probably associated with topiramate. Farm Hosp Organo Of Expresion Cient Soc Espanola Farm Hosp. 2003;27(2):105\u20138.","journal-title":"Farm Hosp Organo Of Expresion Cient Soc Espanola Farm Hosp"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-021-05438-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-021-05438-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-021-05438-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T17:04:20Z","timestamp":1625850260000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-021-05438-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["5438"],"URL":"https:\/\/doi.org\/10.1007\/s11695-021-05438-2","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"type":"print","value":"0960-8923"},{"type":"electronic","value":"1708-0428"}],"subject":[],"published":{"date-parts":[[2021,4,22]]},"assertion":[{"value":"10 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. Informed consent was obtained from the patient for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}